HERON THERAPEUTICS, INC. /DE/ Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Heron Therapeutics, Inc. /De/ quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Heron Therapeutics, Inc. /De/ Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $4.14M, a 36.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.14M -$2.35M -36.2% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $4.79M -$2.28M -32.2% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $5.44M -$2.21M -28.9% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $6.07M -$2.14M -26% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $6.49M -$2.27M -25.9% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $7.07M -$2.22M -23.9% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $7.65M -$2.18M -22.2% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $8.2M -$6M -42.2% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $8.75M -$6.15M -41.3% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $9.3M -$6.3M -40.4% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $9.83M -$6.45M -39.6% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $14.2M -$2.74M -16.2% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $14.9M -$2.69M -15.3% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $15.6M -$2.65M -14.5% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $16.3M +$2.52M +18.3% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $16.9M +$4.7M +38.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $17.6M +$4.93M +38.9% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $18.2M +$5.17M +39.6% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $13.8M +$54K +0.39% Dec 31, 2019 10-K 2021-02-24
Q3 2019 $12.2M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $12.7M Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $13.1M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $13.7M Jan 1, 2019 10-K 2020-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.